Open AccessThe efficacy of lamivudine in the treatment of reactivation of chronic hepatitis B virus infection in patients on immunosuppressive therapy
Author(s) -
Nataša Popović,
Neda Stojkovic-Svirtlih,
Jasmina Simonović-Babić,
Ivan Boričić,
Nada Tomanović,
Nenad Mitrović,
Dragan Delić
Publication year - 2011
Publication title -
srpski arhiv za celokupno lekarstvo
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 17
eISSN - 2406-0895
pISSN - 0370-8179
DOI - 10.2298/sarh1112824p
Subject(s) - medicine , lamivudine , hbsag , prednisolone , gastroenterology , chemotherapy , jaundice , hepatitis b virus , hepatitis , immunology , hepatitis b , virus
Reactivation of chronic hepatitis B virus (HBV) infection often occurs in hepatitis B surface antigen (HBsAg) positive patients undergoing immunosuppressive or chemotherapy, but can also occur in HBsAg negative, anti-HB core positive patients. Treatment of HBV reactivation with lamivudin results in favourable outcome in the majority of patients. The aim of the authors was to show the effect of lamivudin therapy to HBV reactivation caused by immunosuppressive therapy.